CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 228 filers reported holding CONMED CORP in Q1 2019. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $472,000 | -10.9% | 6,781 | +1.6% | 0.00% | 0.0% |
| Q1 2024 | $530,000 | -83.9% | 6,672 | -77.8% | 0.00% | -83.3% |
| Q4 2023 | $3,294,000 | +380.9% | 30,047 | +342.4% | 0.01% | +500.0% |
| Q3 2023 | $685,000 | -29.9% | 6,792 | -5.8% | 0.00% | -50.0% |
| Q2 2023 | $977,000 | +40.8% | 7,208 | +7.3% | 0.00% | 0.0% |
| Q1 2023 | $694,000 | +20.3% | 6,716 | +3.7% | 0.00% | +100.0% |
| Q4 2022 | $577,000 | +30.8% | 6,479 | +18.1% | 0.00% | 0.0% |
| Q3 2022 | $441,000 | +62.1% | 5,485 | +93.5% | 0.00% | 0.0% |
| Q2 2022 | $272,000 | -34.5% | 2,834 | +1.6% | 0.00% | 0.0% |
| Q1 2022 | $415,000 | +4.8% | 2,789 | -0.1% | 0.00% | 0.0% |
| Q4 2021 | $396,000 | +10.6% | 2,793 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $358,000 | +49.2% | 2,736 | +56.8% | 0.00% | 0.0% |
| Q2 2021 | $240,000 | +2.6% | 1,745 | -4.1% | 0.00% | 0.0% |
| Q1 2021 | $234,000 | -79.6% | 1,819 | -86.9% | 0.00% | -87.5% |
| Q1 2019 | $1,146,000 | +16.2% | 13,912 | +3.4% | 0.01% | 0.0% |
| Q2 2018 | $986,000 | – | 13,451 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |